Revenio Group Oyj - Company Announcement

Revenio Group Corporation: PAYING BOARD MEMBERS' FEES IN THE FORM OF SHARES HELD BY THE COMPANY

Revenio Group Corporation Stock Exchange Release, 2nd of May 2013, 10:30 Hrs

PAYING REVENIO GROUP CORPORATION BOARD MEMBERS' FEES IN THE FORM OF SHARES HELD
BY THE COMPANY

With reference to Board meeting fees, Revenio Group Corporation's AGM decided on
21st of March 2013 that 40% of the fee paid to a board member should be paid

in company shares. According to the decisions taken at the AGM and by the Board,
Revenio Group Corporation has transferred to Board members a total of 4.237
shares as a part of their Board fees as follows:

A total of 2.118 shares were transferred to chairman of the Board Pekka Tammela.
As a result of the transfer, his holdings in Revenio Group Corporation and other
instruments issued by Revenio Group Corporation amount to 29.469 shares.

A total of 1.059 shares were transferred to Board member Rolf Fryckman. As a
result of the transfer, his holdings in Revenio Group Corporation and other
instruments issued by Revenio Group Corporation amount to 12.897 shares.

A total of 1.059 shares were transferred to Board member Ari Kohonen. As a
result of the transfer, his and his nearparty holdings in Revenio Group
Corporation and other instruments amount to 341.059 shares.

As a result of these transfers, the share-based Board member fees have been
completely settled for the year 2013. Revenio Group Corporation now holds a
total of 5.357 of its own shares.

Revenio Group Corporation

Olli-Pekka Salovaara

President and CEO

For further information, please contact:

Olli-Pekka Salovaara, President and CEO, GSM +358 (0) 40 567 5520

olli-pekka.salovaara@revenio.fi

Http://www.revenio.fi

DISTRIBUTION:

NASDAQ OMX Helsinki

Financial Supervisory Authority (FIN-FSA)

Key media

www.revenio.fi



The Revenio Group in brief

Revenio is a Finnish health tech group whose core business is tonometers. The
Revenio Health Tech segment comprises the operations of Icare Finland Oy. The
widely patented Icare product family is the current cornerstone of the Group's
success. Revenio seeks vigorous growth in health technology, both organically
and through acquisitions and mergers.

The Revenio Group also includes other business operations, which are grouped
under the Technology and Services segment. This segment's operations have a
shared global market and represent the cutting edge of technology products and
services in their industry. These businesses are extremely profitable in their
industries and generate positive cash flow.

In 2012, the Revenio Group's net sales totaled EUR 25.4 million, with its
operating margin standing at 19.4 percent. The Revenio Group Corporation is
listed on NASDAQ OMX Helsinki.




[HUG#1698566]